Galmed Pharmaceuticals
GLMD
#10238
Rank
C$5.09 M
Marketcap
$2.26
Share price
10.88%
Change (1 day)
-61.85%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$9.08

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$9.26. In 2022 the company made an earnings per share (EPS) of -$14.63 an increase over its 2021 EPS that were of -$27.41.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$9.08-37.98%
2022-$14.63-46.62%
2021-$27.41-2.22%
2020-$28.0339.18%
2019-$20.1470.18%
2018-$11.84-41.84%
2017-$20.35-34.23%
2016-$30.9456.84%
2015-$19.739.2%
2014-$18.07-53.43%
2013-$38.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.79-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.57-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.04-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.27-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA